CytoDyn Inc. (CYDY)
OTCMKTS · Delayed Price · Currency is USD
0.2890
+0.0268 (10.22%)
At close: Mar 26, 2026
CytoDyn Market Cap
CytoDyn has a market cap or net worth of $370.51 million as of March 26, 2026. Its market cap has increased by 16.14% in one year.
Market Cap
370.51M
Enterprise Value
392.79M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.29
Market Cap Chart
Since November 17, 2005, CytoDyn's market cap has increased from 5.54M to 370.51M, an increase of 6,590.78%. That is a compound annual growth rate of 22.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 25, 2026 | 336.15M | -5.48% |
| Dec 31, 2025 | 355.63M | 164.14% |
| Dec 31, 2024 | 134.63M | -29.42% |
| Dec 29, 2023 | 190.74M | 2.63% |
| Dec 30, 2022 | 185.85M | -72.64% |
| Dec 31, 2021 | 679.28M | -78.86% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Northwest Biotherapeutics | 330.22M |
| Silence Therapeutics | 250.81M |
| Vaxart | 163.27M |
| HST Global | 88.40M |
| BioStem Technologies | 84.11M |
| Nuo Therapeutics | 62.78M |
| Anebulo Pharmaceuticals | 40.78M |
| Cell Source | 37.29M |